Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus mFOLFOX6 in advanced colorectal cancer
NCT01529164Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2011
- Primary completion
- Sep 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in colorectal cancer (CRC), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Response Rate at 3 years. Status: unknown.
02
Drugs
endostar
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01529164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529164.